A detailed history of Penn Capital Management Company, LLC transactions in Biomerica Inc stock. As of the latest transaction made, Penn Capital Management Company, LLC holds 20,589 shares of BMRA stock, worth $13,588. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,589
Previous 20,900 1.49%
Holding current value
$13,588
Previous $9,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.28 - $0.49 $87 - $152
-311 Reduced 1.49%
20,589 $6,000
Q4 2023

Feb 14, 2024

SELL
$0.71 - $1.65 $3,428 - $7,967
-4,829 Reduced 18.77%
20,900 $26,000
Q3 2023

Nov 14, 2023

SELL
$0.82 - $1.65 $114 - $231
-140 Reduced 0.54%
25,729 $22,000
Q2 2023

Aug 14, 2023

SELL
$1.12 - $1.87 $1,124 - $1,877
-1,004 Reduced 3.74%
25,869 $35,000
Q1 2023

May 15, 2023

BUY
$1.86 - $3.56 $49,983 - $95,667
26,873 New
26,873 $50,000

Others Institutions Holding BMRA

About BIOMERICA INC


  • Ticker BMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 13,427,700
  • Market Cap $8.86M
  • Description
  • Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...
More about BMRA
Track This Portfolio

Track Penn Capital Management Company, LLC Portfolio

Follow Penn Capital Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penn Capital Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penn Capital Management Company, LLC with notifications on news.